Package 71209-004-10

{"route": ["ORAL"], "spl_id": "9b62ab17-f153-447b-b4d6-78dead35afde", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["dbaf4bf5-57e3-4770-a9b2-d47649e54c1b"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (71209-004-05)", "package_ndc": "71209-004-05", "marketing_start_date": "20181120"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (71209-004-10)", "package_ndc": "71209-004-10", "marketing_start_date": "20181120"}], "brand_name": "Acyclovir", "product_id": "71209-004_9b62ab17-f153-447b-b4d6-78dead35afde", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71209-004", "generic_name": "Acyclovir", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA201445", "marketing_category": "ANDA", "marketing_start_date": "20151229", "listing_expiration_date": "20271231"}